CLINICAL_TRIALS research · 2014-12-24

Clinical Trial Update: Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy.

Completed Amgen-sponsored trial (NCT01813721) evaluating how physicians assess the risk of febrile neutropenia in patients undergoing chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Amgen | Conditions: Chemotherapy-induced Febrile Neutropenia | Status: COMPLETED | Results posted: 2014-12-24